2-237510755-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_024101.7(MLPH):c.292G>A(p.Glu98Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000184 in 1,613,550 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024101.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000282 AC: 43AN: 152254Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000418 AC: 105AN: 251114Hom.: 1 AF XY: 0.000405 AC XY: 55AN XY: 135826
GnomAD4 exome AF: 0.000174 AC: 254AN: 1461296Hom.: 2 Cov.: 31 AF XY: 0.000169 AC XY: 123AN XY: 726942
GnomAD4 genome AF: 0.000282 AC: 43AN: 152254Hom.: 1 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74386
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 21, 2021 | The c.292G>A (p.E98K) alteration is located in exon 3 (coding exon 2) of the MLPH gene. This alteration results from a G to A substitution at nucleotide position 292, causing the glutamic acid (E) at amino acid position 98 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at